Sotera Health (SHC) EBIT (2020 - 2026)

Sotera Health's EBIT history runs 7 years deep, the most recent figure standing at $78.9 million for Q1 2026.

• In Q1 2026, EBIT rose 8.96% year-over-year to $78.9 million; the TTM figure through Mar 2026 stood at $399.3 million (up 26.02% YoY), while the FY2025 annual figure was $392.8 million, up 31.97% from the prior year.
• EBIT was $78.9 million for Q1 2026 at Sotera Health, down from $108.4 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $114.3 million in Q3 2025 to a low of $33.4 million in Q1 2023.
• Historically, EBIT has averaged $76.1 million across 5 years, with a median of $76.1 million in 2023.
• Biggest YoY gain for EBIT was 72.89% in 2023; the steepest drop was 37.62% in 2023.
• A 5-year view of EBIT shows it stood at $60.2 million in 2022, then jumped by 72.89% to $104.0 million in 2023, then retreated by 16.23% to $87.1 million in 2024, then rose by 24.4% to $108.4 million in 2025, then slipped by 27.26% to $78.9 million in 2026.
• The last three EBIT figures came in at $78.9 million (Q1 2026), $108.4 million (Q4 2025), and $114.3 million (Q3 2025), per Business Quant data.